The Mounjaro 7.5mg pen: understanding the third step of treatment

Why the dose schedule is structured the way it is

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that together slow gastric emptying, reduce appetite, and influence blood-sugar regulation. The body needs time to adapt to each increase, which is why the licensed schedule is built around roughly four-week intervals between steps. The 2.5mg starting pen exists purely for tolerance: it is not expected to drive significant weight loss on its own. The 5mg dose begins the therapeutic range for most people. By the time 7.5mg enters the picture, the aim is to push further into that range while keeping side effects manageable.

Prescribers assess this against what you have actually experienced. If 5mg caused persistent nausea or vomiting that did not settle, staying longer at that strength may be the right call before stepping up. If you tolerated it well and weight loss has plateaued, moving forward makes clinical sense. There is no single correct timeline, the schedule is a framework, not a countdown. You can read more about what moving from 5mg to 7.5mg involves and what typically prompts that conversation with a prescriber.

What changes when you move to the 7.5mg pen

For many people, the step to 7.5mg brings a noticeable increase in appetite suppression. Portions feel smaller faster. The sensation of hunger between meals often reduces further. Trial data from the SURMOUNT programme, which enrolled thousands of adults with obesity, showed that continued dose escalation towards higher strengths produced progressively greater average weight reduction, though individual responses vary considerably, and results are always alongside a reduced-calorie diet and increased activity, as the licence specifies. The NHS tirzepatide medicines page gives a clear overview of how the medicine works and what to expect at each stage.

The physical experience of the pen itself does not change between strengths. Each 7.5mg pen is the same KwikPen format, same injection mechanism, same storage conditions (refrigerated at 2–8°C), same rotation of sites across abdomen, thigh, and upper arm. What changes is the dose delivered per weekly injection. Some people notice GI symptoms resurface briefly after stepping up; this is normal and typically settles within a week or two. If they persist or are severe, that is a conversation for your prescriber or aftercare team, not something to manage alone.

When 7.5mg may not be the right move yet

Not everyone progresses through the schedule at the same pace. If the 5mg dose is still producing good results (meaning weight is still reducing steadily and tolerance is comfortable) there may be no clinical reason to increase. Prescribers consider whether the benefit of stepping up outweighs the likelihood of GI side effects returning. Gastrointestinal reactions are the most commonly reported effects across the tirzepatide programme: nausea, loose stools, constipation, reflux, and fatigue are all listed on the patient information leaflet. They are not dangerous for most people, but they can affect daily life, and the right dose is the one a person can actually sustain.

There are also situations where dose escalation is paused: illness, surgery, pregnancy, or a period where eating has been significantly reduced. These are clinical judgements. If you are wondering whether your current dose is doing enough, the overview of the 5mg strength covers the question directly, and our prescribers at nume review every repeat order before dispatch, so there is a natural moment built in to raise this. For a broader look at tirzepatide treatment from the beginning, the Mounjaro treatment guide sets out the full picture.

Getting the 7.5mg pen through a regulated UK pharmacy

Mounjaro is a prescription-only medicine. There is no legal route to the 7.5mg pen without a valid UK prescription following clinical assessment. That means any seller offering it without a prescriber reviewing your case first is operating outside the law, and the MHRA has warned publicly about counterfeit tirzepatide pens circulating online, including a raid on an illicit manufacturing site in 2025. The MHRA Yellow Card scheme is where you can report suspect sellers.

At a legitimate regulated pharmacy, a prescriber reviews your current health picture, your previous dose, how you have been tolerating treatment, and your weight progress before authorising the next pen. At nume, that review happens the same day, a real clinician reads your answers, not software. Orders placed before 12pm on a working day are dispatched the same day once approved, arriving with DPD the next working day in plain packaging. For anyone considering starting treatment or switching from another provider, the process begins with a free consultation. For context on what private treatment typically costs at each dose, the treatment page has current pricing. If you are ready to have a prescriber review your suitability, speak to our prescribers, the consultation is free.